Abivax ADR
Abivax ADR (ABVX) Covered Calls
Loading ABVX covered call opportunities from the prior session (coming three months window)…
Read more
Running ABVX covered calls helps you generate consistent income from Abivax ADR's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Abivax ADR involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ABVX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ABVX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ABVX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Abivax ADR covered call is worth writing.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.
In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
Income-focused investors, long-term ABVX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ABVX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Abivax ADR covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile44.05% Neutral
- Market cap (M$)8,222
- 52 weeks high-36.75%
- 52 weeks low34.84%
- Analyst recommendationStrong Buy
1.26 - Target price$161.18
72.60% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-12-21
- P/E—
- Future P/E—
- EPS (ttm)-6.10
- EPS growth next 5 years42.77%
As of September 23, 2026
No illustrative rows to display.
As of September 23, 2026
Sell covered calls with the data behind you
Find the best ABVX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→